Clinical Applications of Micro- and Nanoscale Biosensors

Biomedical Nanostructures

Volumn , Issue , 2007, Pages 439-460

  Morrison, David W G ^a   Dokmeci, Mehmet R ^b   Demirci, Utkan ^a,c   Khademhosseini, Ali ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Northeastern University   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Micro and nanotechnologies application; Piezoresistive detection; Protein arrays and biosensing applications

Indexed keywords

EID: 84866073754     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470185834.ch17     Document Type: Chapter

References (115)

1. American Cancer Society. Cancer Facts and Figures 2006. Atlanta: American Cancer Society; 2006.
2. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
3. Collings AF and Caruso F. Biosensors: recent advances. Rep Prog Phys 1997;60: 1397-1445.
4. Clark LC Jr and Lyons C. Electrode systems for continuous monitoring in cardiovascular surgery. Ann N Y Acad Sci 1962;102:29-45.
5. Rechnitz GA, Kobos RK, Riechel SJ, Gebauer CR. A bio-selective membrane electrode prepared with living bacterial cells. Anal Chim Acta 1977;94:357-365.
6. Jianrong C, Yuqing M, Nongyue H, Xiaohua W, Sijiao L. Nanotechnology and biosensors. Biotechnol Adv 2004;22:505-518.
7. Whitesides GM, Ostuni E, Takayama S, Jiang XY, Ingber DE. Soft lithography in biology and biochemistry. Annu Rev Biomed Eng 2001;3:335-373.
8. Kubik T, Bogunia-Kubik K, Sugisaka M. Nanotechnology on duty in medical applications. Curr Pharm Biotechnol 2005;6:17-33.
9. Monk DJ and Walt DR. Optical fiber-based biosensors. Anal Bioanal Chem 2004;379:931-945.
10. Vo-Dinh T and Cullum B. Biosensors and biochips: advances in biological and medical diagnostics. Fresenius J Anal Chem 2000;366:540-551.
11. Suh KY, Khademhosseini A, Yoo PJ, Langer R. Fabrication of single or aggregated bacteria arrays using host-parasite and virus-antibody interactions. Biomed Microdevices 2004;6:223-229.
12. Suh KY, Khademhosseini A, Jon S, Langer R. Direct confinement of individual viruses within polyethylene glycol (PEG) nanowells. Nano Lett 2006;6:1196-1201.
13. Hermann T and Patel DJ. Adaptive recognition by nucleic acid aptamers. Science 2000;287:820-825.
14. Ramanathan K and Danielsson B. Principles and applications of thermal biosensors. Biosens Bioelectron 2001;16:417-423.
15. Newman JD, Warner PJ, Turner APF, Tigwell LJ. Biosensors: A Clearer View. UK: Cranfield University; 2004; p 216.
16. Cheng MM, et al. Nanotechnologies for biomolecular detection and medical diagnostics. Curr Opin Chem Biol 2006;10:11-19.
17. Ziegler C. Cantilever-based biosensors. Anal Bioanal Chem 2004;379:946-959.
18. Yang Y, Ji HF, Thundat T. Nerve agents detection using a Cu2+/L-cysteine bilayer-coated microcantilever. J Am Chem Soc 2003;125:1124-1125.
19. Wu G, et al. Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat Biotechnol 2001;19:856-860.
20. Hansen KM and Thundat T. Microcantilever biosensors. Methods 2005;37:57-64.
21. Mukhopadhyay R, et al. Cantilever sensor for nanomechanical detection of specific protein conformations. Nano Lett 2005;5:2385-2388.
22. Lavrik NV, Separiak M, Datskos PG. Cantilever transducers as a platform for chemical and biological sensors. Rev Sci Instrum 2004;75:2229-2253.
23. Demirci U, Ergun A, Oralkan O, Karaman M, Khuri-Yakub B. Forward-viewing CMUT arrays for medical imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2004;51:887-895.
24. Rider TH, et al. A B cell-based sensor for rapid identification of pathogens. Science 2003;301:213-215.
25. Powers MJ, et al. A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng 2002;78:257-269.
26. Natarajan A, Molnar P, Sieverdes K, Jamshidi A, Hickman JJ. Microelectrode array recordings of cardiac action potentials as a high throughput method to evaluate pesticide toxicity. Toxicol In Vitro 2006;20:375-381.
27. Fairey ER, Bottein Dechraoui MY, Sheets MF, Ramsdell JS. Modification of the cell based assay for brevetoxins using human cardiac voltage dependent sodium channels expressed in HEK-293 cells. Biosens Bioelectron 2001;16: 579-586.
28. Gray SA, et al. Design and demonstration of an automated cell-based biosensor. Biosens Bioelectron 2001;16:535-542.
29. Kim H, Doh J, Irvine DJ, Cohen RE, Hammond PT. Large area two-dimensional B cell arrays for sensing and cell-sorting applications. Biomacromolecules 2004;5:822-827.
30. Doh J and Irvine DJ. Immunological synapse arrays: patterned protein surfaces that modulate immunological synapse structure formation in T cells. Proc Natl Acad Sci USA 2006;103:5700-5705.
31. Khademhosseini A, Langer R, Borenstein J, Vacanti JP. Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci USA 2006;103:2480-2487.
32. Koh WG, Itle LJ, Pishko MV. Molding of hydrogel multiphenotype cell microstructures to create microarrays. Anal Chem 2003;75:5783-5789.
33. Kim H, Cohen RE, Hammond PT, Irvine DT. Live lymphocyte arrays for biosensing. Adv Func Mater 2006;16:1313-1323.
34. Khademhosseini A, et al. Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays. Lab Chip 2005;5:1380-1386.
35. Taitt CR, Anderson GP, Lingerfelt BM, Feldstein MJ, Ligler FS. Nine-analyte detection using an array-based biosensor. Anal Chem 2002;74:6114-6120.
36. Taitt CR, et al. A portable array biosensor for detecting multiple analytes in complex samples. Microb Ecol 2004;47:175-185.
37. Ligler FS, et al. Array biosensor for detection of toxins. Anal Bioanal Chem 2003;377:469-477.
38. Whitesides GM. The 'right' size in nanobiotechnology. Nat Biotechnol 2003; 21:1161-1165.
39. Monson E, Brasuel MA, Philbert A, Kopelman R. PEBBLE nanosensors for in vitro analysis. In: Vo-Dinh T, editor. Biomedical Photonics Handbook. Boca Raton, FL: CRC Press; 2003.
40. Cao Y, Lee Koo YE, Kopelman R. Poly(decyl methacrylate)-based fluorescent PEBBLE swarm nanosensors for measuring dissolved oxygen in biosamples. Analyst 2004;129:745-750.
41. Park EJ, Brasuel M, Behrend C, Philbert MA, Kopelman R. Ratiometric optical PEBBLE nanosensors for real-time magnesium ion concentrations inside viable cells. Anal Chem 2003;75:3784-3791.
42. Xu H, Aylott JW, Kopelman R. Fluorescent nano-PEBBLE sensors designed for intracellular glucose imaging. Analyst 2002;127:1471-1477.
43. Sumner JP, Aylott JW, Monson E, Kopelman R. A fluorescent PEBBLE nanosensor for intracellular free zinc. Analyst 2002;127:11-16.
44. Clark HA, Hoyer M, Philbert MA, Kopelman R. Optical nanosensors for chemical analysis inside single living cells. 1. Fabrication, characterization, and methods for intracellular delivery of PEBBLE sensors,Anal Chem 1999;71: 4831-4836.
45. Clark HA, Kopelman R, Tjalkens R, Philbert MA. Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. Anal Chem 1999;71:4837-4843.
46. Buck SM, et al. Optochemical nanosensor PEBBLEs: photonic explorers for bioanalysis with biologically localized embedding. Curr Opin Chem Biol 2004;8:540-546.
47. Wolfbeis OS. Fiber-optic chemical sensors and biosensors. Anal Chem 2000; 72:81R-89R.
48. Brasuel M, Kopelman R, Miller TJ, Tjalkens R, Philbert MA. Fluorescent nanosensors for intracellular chemical analysis: decyl methacrylate liquid polymer matrix and ion-exchange-based potassium PEBBLE sensors with real-time application to viable rat C6 glioma cells. Anal Chem 2001;73:2221-2228.
49. Xu H, Aylott JW, Kopelman R, Miller TJ, Philbert MA. A real-time ratiometric method for the determination of molecular oxygen inside living cells using sol-gelbased spherical optical nanosensors with applications to rat C6 glioma. Anal Chem 2001;73:4124-4133.
50. Alivisatos AP, Gu W, Larabell C. Quantum dots as cellular probes. Annu Rev Biomed Eng 2005;7:55-76.
51. Mansson A, et al. In vitro sliding of actin filaments labelled with single quantum dots. Biochem Biophys Res Commun 2004;314:529-534.
52. Smith AM, Dave S, Nie S, True L, Gao X. Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn 2006;6:231-244.
53. Tomlinson ID, Mason JN, Blakely RD, Rosenthal SJ. Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells. Methods Mol Biol 2005;303:51-60.
54. Dai Q, et al. Colloidal CdSe nanocrystals synthesized in noncoordinating solvents with the addition of a secondary ligand: exceptional growth kinetics. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 2006;110:16508-16513.
55. Jang E, Jun S, Pu L. High quality CdSeS nanocrystals synthesized by facile single injection process and their electroluminescence. Chem Commun (Camb) 2003: 2964-2965.
56. Skaff H, Sill K, Emrick T. Quantum dots tailored with poly(para-phenylene vinylene). J Am Chem Soc 2004;126:11322-11325.
57. Crouch D, Norager S, O'Brien P, Park JH, Pickett N. New synthetic routes for quantum dots. Philos Trans A Math Phys Eng Sci 2003;361.297-310. discussion 310
58. Alivisatos P. The use of nanocrystals in biological detection. Nat Biotechnol 2004;22:47-52.
59. Chan WC and Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998;281:2016-2018.
60. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004;22:969-976
61. Wu X, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003;21:41-46.
62. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 2003;21:47-51.
63. Derfus AM, Chan WCW, Bhatia SN. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv Mater 2004;16:961-966.
64. Hoehn M, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002;99:16267-16272.
65. Yeh TC, Zhang W, Ildstad ST, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn Reson Med 1995;33: 200-208.
66. Dardzinski BJ, et al. MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles. Magn Reson Imaging 2001;19:1209-1216.
67. Ito A, Shinkai M, Honda H, Kobayashi T. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 2005;100:1-11.
68. Hinds KA, et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003;102:867-872.
69. Shapiro EM, et al. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 2004;101:10901-10906.
70. Kalish H, et al. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med 2003;50:275-282.
71. Turner AP, Chen B, Piletsky SA. In vitro diagnostics in diabetes: meeting the challenge. Clin Chem 1999;45:1596-1601.
72. Wilson GS and Hu Y. Enzyme-based biosensors for in vivo measurements. Chem Rev 2000;100:2693-2704.
73. Newman JD and Turner AP. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron 2005;20:2435-2453.
74. Pickup JC, Hussain F, Evans ND, Sachedina N. In vivo glucose monitoring: the clinical reality and the promise. Biosens Bioelectron 2005;20:1897-1902.
75. Bolinder J, Ungerstedt U, Arner P. Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patients. Diabetologia 1992;35:1177-1180.
76. Nicolle L. Epidemiology of urinary tract infection. Infect Med 2001;18:153-162.
77. Liao JC, et al. Use of electrochemical DNA biosensors for rapid molecular identification of uropathogens in clinical urine specimens. J Clin Microbiol 2006;44:561-570.
78. Wang J. Electrochemical nucleic acid biosensors. Anal Chim Acta 2002;469: 63-71.
79. Drummond TG, Hill MG, Barton JK. Electrochemical DNA sensors. Nat Biotechnol 2003;21:1192-1199.
80. Campbell CN, Gal D, Cristler N, Banditrat C, Heller A. Enzyme-amplified amperometric sandwich test for RNA and DNA. Anal Chem 2002;74:158-162
81. Sia SK, Linder V, Parviz BA, Siegel A, Whitesides GM. An integrated approach to a portable and low-cost immunoassay for resource-poor settings. Angew Chem Int Ed Engl 2004;43:498-502.
82. Christodoulides N, et al. A microchip-based multianalyte assay system for the assessment of cardiac risk. Anal Chem 2002;74:3030-3036.
83. Whiley DM and Sloots TP. A 5'-nuclease real-time reverse transcriptasepolymerase chain reaction assay for the detection of a broad range of influenza A subtypes, including H5N1. Diagn Microbiol Infect Dis 2005;53:335-337.
84. Ivanov AP and Dragunsky EM. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Rev Vaccines 2005;4:167-172.
85. Rich JD, et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med 1999;130:37-39.
86. van Elden LJ, Nijhuis M, Schipper P, Schuurman R, van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 2001;39:196-200.
87. Rich R.L and Myszka DG. Spying on HIV with SPR. Trends Microbiol 2003; 11:124-133.
88. Myszka DG and Rich RL. Implementing surface plasmon resonance biosensors in drug discovery. Pharm Sci Technol Today 2000;3:310-317.
89. Fagerstam LG, et al. Detection of antigen-antibody interactions by surface plasmon resonance. Application to epitope mapping. J Mol Recognit 1990;3: 208-214.
90. Alterman M, et al. P1/P10 modified HIV protease inhibitors as tools in two new sensitive surface plasmon resonance biosensor screening assays. Eur J Pharm Sci 2001;13:203-212.
91. Toner M and Irimia D. Blood-on-a-chip. Annu Rev Biomed Eng 2005;7:77-103.
92. Grodzinski P, Silver M, Molnar LK. Nanotechnology for cancer diagnostics: promises and challenges. Expert Rev Mol Diagn 2006;6:307-318.
93. Fehm T, et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073-2084.
94. Cristofanilli M, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-791.
95. Judson PL, et al. Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer. Gynecol Oncol 2003;91:389-394
96. Moreno JG, et al. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology 2001;58:386-392.
97. Racila E, et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998;95:4589-4594.
98. Raynor M, Stephenson SA, Walsh DC, Pittman KB, Dobrovic A. Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells. BMC Cancer 2002;2:14.
99. Smirnov DA, et al. Global gene expression profiling of circulating tumor cells. Cancer Res 2005;65:4993-4997.
100. Shigematsu H, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-346.
101. Moreno JG, et al. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology 2005;65:713-718.
102. Vona G, et al. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004;39:792-797.
103. Witzig T.E, et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 2002;8:1085-1091.
104. Zieglschmid V, Hollmann C, Bocher O. Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci 2005;42:155-196.
105. Rolle A, et al. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC is a predictor for relapse: a preliminary report. World J Surg Oncol 2005;3:18.
106. O'Hara SM, et al. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem 2004;50:826-835.
107. Momburg F, Moldenhauer G, Hammerling GJ, Moller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987;47:2883-2891.
108. Stoop JA, Hendriks JG, Berends D. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA. Cytopathology 1992;3:297-302.
109. Gaffey MJ, et al. Immunoreactivity for BER-EP4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas. Am J Surg Pathol 1992;16: 593-599.
110. Rao CG, et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 2005;27:49-57.
111. Mohamed H, et al. Development of a rare cell fractionation device: application for cancer detection. IEEE Trans Nanobiosci 2004;3:251-256.
112. Shelby JP, White J, Ganesan K, Rathod PK, Chiu DT. A microfluidic model for single-cell capillary obstruction by Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci USA 2003;100:14618-14622.
113. Farokhzad OC, et al. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res 2004;64:7668-7672.
114. Harishinghani MG, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348:2491-2499.
115. Battiston FM, et al. A chemical sensor based on a microfabricated cantilever array with simultaneous resonance-frequency and bending readout. Sens Actuators 2001;77:122-131.